Stefin B Inhibits NLRP3 Inflammasome Activation via AMPK/mTOR Signalling
Cells · 2023
DOI: 10.3390/cells12232731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Mojca Trstenjak-Prebanda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Molecular and Structural Biology, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Cystatin B, Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research Agency.
Abstract (Originalsprache)
Stefin B (cystatin B) is an inhibitor of lysosomal and nuclear cysteine cathepsins. The gene for stefin B is located on human chromosome 21 and its expression is upregulated in the brains of individuals with Down syndrome. Biallelic loss-of-function mutations in the stefin B gene lead to Unverricht–Lundborg disease-progressive myoclonus epilepsy type 1 (EPM1) in humans. In our past study, we demonstrated that mice lacking stefin B were significantly more sensitive to sepsis induced by lipopolysaccharide (LPS) and secreted higher levels of interleukin 1-β (IL-1β) due to increased inflammasome activation in bone marrow-derived macrophages. Here, we report lower interleukin 1-β processing and caspase-11 expression in bone marrow-derived macrophages prepared from mice that have an additional copy of the stefin B gene. Increased expression of stefin B downregulated mitochondrial reactive oxygen species (ROS) generation and lowered the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in macrophages. We determined higher AMP-activated kinase phosphorylation and downregulation of mTOR activity in stefin B trisomic macrophages—macrophages with increased stefin B expression. Our study showed that increased stefin B expression downregulated mitochondrial ROS generation and increased autophagy. The present work contributes to a better understanding of the role of stefin B in regulation of autophagy and inflammasome activation in macrophages and could help to develop new treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Molecular and Structural Biology, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia.
- International Postgraduate School Jožef Stefan, SI-1000 Ljubljana, Slovenia.
- Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
- Faculty of Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM, CNRS, Université de Strasbourg, 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, France.
- Institut Clinique de la Souris, PHENOMIN, CELPHEDIA, INSERM, CNRS, Universite' de Strasbourg, 67404 Illkirch Graffenstaden, France.
ORCID-Profile: Klemen Dolinar, Sergej Pirkmajer, Boris Turk, Veronique Brault, Yann Herault, Nataša Kopitar-Jerala
Förderung
- Slovenian Research Agency
Zitieren
APA
Trstenjak-Prebanda, M., Biasizzo, M., Dolinar, K., Pirkmajer, S., Turk, B., Brault, V., Herault, Y., & Kopitar-Jerala, N. (2023). Stefin B Inhibits NLRP3 Inflammasome Activation via AMPK/mTOR Signalling. Cells. https://doi.org/10.3390/cells12232731
Vancouver
Trstenjak-Prebanda M, Biasizzo M, Dolinar K, Pirkmajer S, Turk B, Brault V, et al. Stefin B Inhibits NLRP3 Inflammasome Activation via AMPK/mTOR Signalling. Cells. 2023. doi:10.3390/cells12232731
BibTeX
@article{TrstenjakPrebanda2023,
author = {Trstenjak-Prebanda, Mojca and Biasizzo, Monika and Dolinar, Klemen and Pirkmajer, Sergej and Turk, Boris and Brault, Veronique and Herault, Yann and Kopitar-Jerala, Nataša},
title = {Stefin B Inhibits NLRP3 Inflammasome Activation via AMPK/mTOR Signalling},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12232731}
}
EUVIMED